ACHIEVE LIFE SCIENCES INC. - COMMON SHARES

Achieve Life Sciences Announces FDA Grants Breakthrough Therapy Designation to Cytisinicline for the Treatment of E-Cigarette or Vaping Nicotine Dependence

31 Jul 2024 08:00:06 By Nasdaq GlobeNewswire

Achieve Life Sciences Announces $20M Loan Refinancing with Silicon Valley Bank

29 Jul 2024 08:00:00 By Nasdaq GlobeNewswire

Achieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 13, 2024

25 Jul 2024 08:00:00 By Nasdaq GlobeNewswire

Achieve Life Sciences to Present at JonesHealthcare Seaside Summit 2024

09 Jul 2024 08:00:00 By Nasdaq GlobeNewswire

Achieve Life Sciences Announces Addition to the U.S. Russell 3000® and Russell Microcap® Indexes

01 Jul 2024 08:00:00 By Nasdaq GlobeNewswire

Achieve Life Sciences Announces Initiation of ORCA-OL Clinical Trial Evaluating Long-Term Exposure of Cytisinicline in People who Smoke or Use Nicotine E-Cigarettes

29 May 2024 08:00:01 By Nasdaq GlobeNewswire

Achieve Life Sciences Announces Data from Cytisinicline ORCA-V1 Program to be Presented at Society of General Internal Medicine (SGIM) Annual Meeting

17 May 2024 08:00:29 By Nasdaq GlobeNewswire

Achieve Life Sciences Reports Financial Results for First Quarter 2024 and Provides Corporate Update

09 May 2024 16:01:28 By Nasdaq GlobeNewswire

Achieve Life Sciences Announces Publication of Cytisinicline Vaping Cessation Trial Results in JAMA Internal Medicine

06 May 2024 11:16:04 By Nasdaq GlobeNewswire

Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 9, 2024

25 Apr 2024 08:00:00 By Nasdaq GlobeNewswire

Achieve Life Sciences to Present at Life Science Innovation Northwest 2024 Conference

11 Apr 2024 08:00:00 By Nasdaq GlobeNewswire

Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2023 and Provides Corporate Update

28 Mar 2024 16:01:21 By Nasdaq GlobeNewswire

Achieve Life Sciences Announces Data from Cytisinicline ORCA Program to be Presented at the 2024 Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting

20 Mar 2024 08:00:00 By Nasdaq GlobeNewswire

Achieve Life Sciences to Announce Fourth Quarter and Year-End 2023 Financial Results and Host Conference Call and Webcast on March 28, 2024

14 Mar 2024 08:00:00 By Nasdaq GlobeNewswire

Achieve Life Sciences Announces Participation at Upcoming Investor Conferences

06 Mar 2024 08:00:00 By Nasdaq GlobeNewswire

Achieve Life Sciences Reaches Agreement with the FDA on Long-Term Cytisinicline Exposure Data Requirements for NDA Submission

29 Feb 2024 08:01:00 By Nasdaq GlobeNewswire

Achieve Life Sciences Announces Pricing of up to $124.2 Million Registered Direct Offering and Concurrent Private Placement

29 Feb 2024 08:00:00 By Nasdaq GlobeNewswire

Achieve Life Sciences Announces Participation at Upcoming Investor Conferences

11 Dec 2023 16:30:00 By Nasdaq GlobeNewswire

Achieve Life Sciences Reports Financial Results for Third Quarter and Provides Corporate Update

09 Nov 2023 16:00:00 By Nasdaq GlobeNewswire

Achieve Life Sciences to Announce Third Quarter 2023 Financial Results and Host Conference Call and Webcast on November 9, 2023

26 Oct 2023 08:00:00 By Nasdaq GlobeNewswire